HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
IMCAS 2024 is over.
The HTL team was delighted to welcome everyone on our booth to discuus the latest trends in aesthetic care, to meet industry experts and discover the latest innovations in dermatology, plastic surgery, and aesthetic science treatments.
We were proud to sponsor the Innovation Tank of IMCAS 2024, where Anne Laure GAUDRY, Head of Innovation and R&D at HTL Biotechnology, was part of the jury awarding the prize for innovation of the year.
See you next year !
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.
HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.